GNRH1 and endometriosis: Treatment prior to surgery in the endometriosis group was heterogeneous, including NSAIDs (36.11%), GnRH agonists (19.44%), dienogest (19.44%), DMPA (16.67%), and combined oral contraceptives (2.78%), while 5.56% of patients received no medication.